These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7590830)

  • 1. Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides.
    Alving CR; Koulchin V; Glenn GM; Rao M
    Immunol Rev; 1995 Jun; 145():5-31. PubMed ID: 7590830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T lymphocytes induced by liposomal antigens: mechanisms of immunological presentation.
    Alving CR; Wassef NM
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S91-4. PubMed ID: 7532427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a.
    Kohyama S; Ohno S; Suda T; Taneichi M; Yokoyama S; Mori M; Kobayashi A; Hayashi H; Uchida T; Matsui M
    Antiviral Res; 2009 Nov; 84(2):168-77. PubMed ID: 19748524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil.
    Rao M; Alving CR
    Adv Drug Deliv Rev; 2000 Mar; 41(2):171-88. PubMed ID: 10699313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes.
    Beck Z; Karasavvas N; Matyas GR; Alving CR
    J Drug Target; 2008 Aug; 16(7):535-42. PubMed ID: 18686123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.
    Guan HH; Budzynski W; Koganty RR; Krantz MJ; Reddish MA; Rogers JA; Longenecker BM; Samuel J
    Bioconjug Chem; 1998; 9(4):451-8. PubMed ID: 9667946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy for efficient cross-presentation of CTL-epitope peptides leading to enhanced induction of in vivo tumor immunity.
    Hayashi A; Wakita H; Yoshikawa T; Nakanishi T; Tsutsumi Y; Mayumi T; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
    J Control Release; 2007 Jan; 117(1):11-9. PubMed ID: 17126444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory.
    Gregoriadis G; Wang Z; Barenholz Y; Francis MJ
    Immunology; 1993 Dec; 80(4):535-40. PubMed ID: 7508417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspective of Peptide Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers.
    Lee Y; Lee YS; Cho SY; Kwon HJ
    Adv Protein Chem Struct Biol; 2015; 99():75-97. PubMed ID: 26067817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine.
    Huang W; Nardelli B; Tam JP
    Mol Immunol; 1994 Oct; 31(15):1191-9. PubMed ID: 7935506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.
    Karasavvas N; Beck Z; Tong J; Matyas GR; Rao M; McCutchan FE; Michael NL; Alving CR
    Biochem Biophys Res Commun; 2008 Feb; 366(4):982-7. PubMed ID: 18088597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells.
    Lipford GB; Wagner H; Heeg K
    Vaccine; 1994 Jan; 12(1):73-80. PubMed ID: 8303944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice.
    Ninomiya A; Ogasawara K; Kajino K; Takada A; Kida H
    Vaccine; 2002 Aug; 20(25-26):3123-9. PubMed ID: 12163263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes as carriers of antigens and adjuvants.
    Alving CR
    J Immunol Methods; 1991 Jun; 140(1):1-13. PubMed ID: 1712030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation.
    Babu JS; Nair S; Kanda P; Rouse BT
    Vaccine; 1995 Dec; 13(17):1669-76. PubMed ID: 8719518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant.
    Jérôme V; Graser A; Müller R; Kontermann RE; Konur A
    J Immunother; 2006; 29(3):294-305. PubMed ID: 16699372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of hybrid CTL epitope delivery systems consisting of the Antennapedia homeodomain peptide vector formulated in liposomes.
    Chikh G; Bally M; Schutze-Redelmeier MP
    J Immunol Methods; 2001 Aug; 254(1-2):119-35. PubMed ID: 11406158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens.
    Phillips NC; Gagné L; Ivanoff N; Riveau G
    Vaccine; 1996 Jun; 14(9):898-904. PubMed ID: 8843632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal delivery of CTL epitopes to dendritic cells.
    Chikh G; Schutze-Redelmeier MP
    Biosci Rep; 2002 Apr; 22(2):339-53. PubMed ID: 12428909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells.
    Toes RE; van der Voort EI; Schoenberger SP; Drijfhout JW; van Bloois L; Storm G; Kast WM; Offringa R; Melief CJ
    J Immunol; 1998 May; 160(9):4449-56. PubMed ID: 9574550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.